Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

about

Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates.Formal modeling and analysis of ER-α associated Biological Regulatory Network in breast cancer.

P2860

Q33718841-98F789C3-F130-4A00-B2FF-34C37E7F399C Q37359952-DC9D04AE-89C6-46F0-8E64-2DA7322A6215

P2860

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

Item

http://www.wikidata.org/entity/Q38943947

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.

@en

type

Item

label

Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.

@en

prefLabel

Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.

@en

P1476

Inhibition of EGFR or IGF-1R s ...... nhibition has no added benefit

@en

P2093

David P Molkentine

http://www.w3.org/2001/XMLSchema#string

David R Valdecanas

http://www.w3.org/2001/XMLSchema#string

Heath Skinner

http://www.w3.org/2001/XMLSchema#string

Kathryn A Mason

http://www.w3.org/2001/XMLSchema#string

Kie-Kian Ang

http://www.w3.org/2001/XMLSchema#string

Raymond E Meyn

http://www.w3.org/2001/XMLSchema#string

Thomas A Buchholz

http://www.w3.org/2001/XMLSchema#string

Uma Raju

http://www.w3.org/2001/XMLSchema#string

P2860

Cell signaling by receptor tyrosine kinases

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.

Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.

Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair

Combining molecular therapeutics with radiotherapy for head and neck cancer.

Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer.

P304

65-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.345

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amit Deorukhkar

P577

2014-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267571522

http://www.w3.org/2001/XMLSchema#string

P698

25355701

http://www.w3.org/2001/XMLSchema#string

P932

4312119

http://www.w3.org/2001/XMLSchema#string

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

about

P2860

P2860

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932